Profil
Sheldon Aberman worked as the Director & Chief Cannabis Officer at Chemistree Technology, Inc. from 2019 to 2023.
He was also the President of Cannabis Consulting, Inc. and the Chief Information Officer of Canadian Cannabis Corp.
Anciens postes connus de Sheldon Aberman
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMISTREE TECHNOLOGY INC. | Director/Board Member | 08/01/2023 |
Cannabis Consulting, Inc.
 Cannabis Consulting, Inc. Investment ManagersFinance Part of Cannabis Science, Inc., Cannabis Consulting, Inc. provides investment advice to the medical cannabis industry. The private company is based in Bound Brook, NJ. Cannabis Consulting was acquired by Cannabis Science, Inc. on March 21, 2012 for $0.09 million. | President | - |
| CANADIAN CANNABIS CORP. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHEMISTREE TECHNOLOGY INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Cannabis Consulting, Inc.
Cannabis Consulting, Inc. Investment ManagersFinance Part of Cannabis Science, Inc., Cannabis Consulting, Inc. provides investment advice to the medical cannabis industry. The private company is based in Bound Brook, NJ. Cannabis Consulting was acquired by Cannabis Science, Inc. on March 21, 2012 for $0.09 million. | Finance |
Canadian Cannabis Corp.
 Canadian Cannabis Corp. Pharmaceuticals: OtherHealth Technology Canadian Cannabis Corp. engages in the production, development, and distribution of medical marijuana. It operates through the Medical Marijuana Cultivation Business and Horticultural Lighting Business segments. It owns and operates marijuana production facility and engages in clinical trials, cannabis-derived strains, and pharmaceutical products. The company was founded on January 20, 2014 and is headquartered in Oakville, Canada. | Health Technology |
